S. Taillibert, L. Rhun, and É. ,

, Cancer Radiother J Soc Francaise Radiother Oncol, vol.19, pp.3-9, 2015.

P. W. Sperduto, N. Kased, D. Roberge, Z. Xu, R. Shanley et al., Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases, J Clin Oncol

E. Weltman, J. V. Salvajoli, R. A. Brandt, R. De-morais-hanriot, F. E. Prisco et al., Radiosurgery for brain metastases: a score index for predicting prognosis, Int J Radiat Oncol Biol Phys, vol.46, pp.1155-61, 2000.

A. Bajard, V. Westeel, A. Dubiez, P. Jacoulet, D. Pernet et al., Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma, Lung Cancer Amst Neth, vol.45, pp.317-340, 2004.

G. L. Ceresoli, M. Reni, G. Chiesa, A. Carretta, S. Schipani et al., Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis, Cancer, vol.95, pp.605-617, 2002.

L. J. Schouten, J. Rutten, H. Huveneers, and A. Twijnstra, Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma, Cancer, vol.94, pp.2698-705, 2002.

P. W. Sperduto, T. J. Yang, K. Beal, H. Pan, P. D. Brown et al., Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

, JAMA Oncol, vol.3, pp.827-858, 2017.

W. Jacot, X. Quantin, J. M. Boher, F. Andre, L. Moreau et al., Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors, Br J Cancer, vol.84, pp.903-912, 2001.

D. N. Cagney, A. M. Martin, P. J. Catalano, A. J. Redig, N. U. Lin et al., Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study, Neuro-Oncol, vol.19, pp.1511-1532, 2017.

S. Peters, C. Bexelius, V. Munk, and N. Leighl, The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer, Cancer Treat Rev, vol.45, pp.139-62, 2016.

, Collège National des Gynécologues et Obstétricien Francais -Université médicale virtuelle francophone

Y. Tsukada, A. Fouad, J. W. Pickren, and W. W. Lane, Central nervous system metastasis from breast carcinoma. Autopsy study, Cancer, vol.52, pp.2349-54, 1983.

J. S. Barnholtz-sloan, A. E. Sloan, F. G. Davis, F. D. Vigneau, P. Lai et al., Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System, J Clin Oncol, vol.22, pp.2865-72, 2004.

H. Kennecke, R. Yerushalmi, R. Woods, M. Cheang, D. Voduc et al., Metastatic behavior of breast cancer subtypes, J Clin Oncol, vol.28, pp.3271-3278, 2010.

N. U. Lin, C. E. Sohl, J. Razzak, A. R. Arnaout, A. Winer et al., Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases, Cancer, vol.113, pp.2638-2683, 2008.

A. J. Evans, J. J. James, E. J. Cornford, S. Y. Chan, H. C. Burrell et al., Brain metastases from breast cancer: identification of a high-risk group, Clin Oncol R Coll Radiol G B, vol.16, pp.345-354, 2004.

S. Gori, S. Rimondini, D. Angelis, V. Colozza, M. Bisagni et al., Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors, The Oncologist, vol.12, pp.766-73, 2007.

K. Slimane, F. Andre, S. Delaloge, A. Dunant, A. Perez et al., Risk factors for brain relapse in patients with metastatic breast cancer, Ann Oncol, vol.15, pp.1640-1644, 2004.

M. Ryberg, D. Nielsen, K. Osterlind, P. K. Andersen, T. Skovsgaard et al., Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy, Breast Cancer Res Treat, vol.91, pp.217-242, 2005.

P. W. Sperduto, N. Kased, D. Roberge, S. T. Chao, R. Shanley et al., The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer, J Neurooncol, vol.112, pp.467-72, 2013.

K. Altundag, M. L. Bondy, N. Q. Mirza, S. Kau, K. Broglio et al., Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis, Cancer, vol.110, pp.2640-2647, 2007.

M. Diener-west, T. W. Dobbins, T. L. Phillips, and D. F. Nelson, Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916, Int J Radiat Oncol Biol Phys, vol.16, pp.669-73, 1989.

M. Qian, M. W. Ma, N. H. Fleming, D. J. Lackaye, H. E. Osman et al., Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis, Melanoma Res, vol.23, pp.461-468, 2013.

M. Qian, M. W. Ma, N. H. Fleming, D. J. Lackaye, H. E. Osman et al., Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis, Melanoma Res, vol.23, pp.461-468, 2013.

M. A. Davies, P. Liu, S. Mcintyre, K. B. Kim, N. Papadopoulos et al., Prognostic factors for survival in melanoma patients with brain metastases, Cancer, vol.117, pp.1687-96, 2011.

A. Y. Bedikian, C. Wei, M. Detry, K. B. Kim, N. E. Papadopoulos et al., Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma, Am J Clin Oncol, vol.34, pp.603-613, 2011.

O. Gumusay, U. Coskun, T. Akman, A. S. Ekinci, M. Kocar et al., Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology, J Cancer Res Clin Oncol, vol.140, pp.151-158, 2014.

E. Frinton, D. Tong, J. Tan, G. Read, V. Kumar et al., Metastatic melanoma: prognostic factors and survival in patients with brain metastases, J Neurooncol, vol.135, pp.507-519, 2017.

J. A. Jakob, R. L. Bassett, C. S. Ng, J. L. Curry, R. W. Joseph et al., NRAS mutation status is an independent prognostic factor in metastatic melanoma, Cancer, vol.118, pp.4014-4037, 2012.

J. Zakrzewski, L. N. Geraghty, A. E. Rose, P. J. Christos, M. Mazumdar et al., Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival, Cancer, vol.117, pp.1711-1731, 2011.

M. S. Carlino, G. B. Fogarty, and G. V. Long, Treatment of melanoma brain metastases: a new paradigm, Cancer J Sudbury Mass, vol.18, pp.208-220, 2012.

J. J. Raizer, W. Hwu, K. S. Panageas, A. Wilton, D. E. Baldwin et al., Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features, Neuro-Oncol, vol.10, pp.199-207, 2008.

C. Nieder, A. Pawinski, and L. Balteskard, Colorectal cancer metastatic to the brain: time trends in presentation and outcome, Oncology, vol.76, pp.369-74, 2009.

B. Shuch, L. Rochelle, J. C. Klatte, T. Riggs, S. B. Liu et al., Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival, Cancer, vol.113, pp.1641-1649, 2008.

S. Y. Choi, S. Yoo, D. You, I. G. Jeong, C. Song et al., Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma, Clin Genitourin Cancer, vol.15, pp.717-740, 2017.

I. A. Bowman, A. Bent, T. Le, A. Christie, Z. Wardak et al., Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases, Clin Genitourin Cancer, vol.17, pp.263-72, 2019.

J. P. Mongan, C. E. Fadul, B. F. Cole, B. I. Zaki, A. A. Suriawinata et al., Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines, Clin Colorectal Cancer, vol.8, pp.100-105, 2009.

J. Y. Baek, M. H. Kang, Y. S. Hong, T. W. Kim, D. Y. Kim et al., Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy, J Neurooncol, vol.104, pp.745-53, 2011.

C. Fountzilas, K. Chang, B. Hernandez, J. Michalek, R. Crownover et al., Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience, J Gastrointest Oncol, vol.8, pp.55-63, 2017.

R. Yaeger, E. Cowell, J. F. Chou, A. N. Gewirtz, L. Borsu et al., RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer, Cancer, vol.121, pp.1195-203, 2015.

, ANOCEF -Association des Neuro-oncologues d'Expression Française

, Nanterre : Santor Edition

I. Latorzeff, A. D. , G. , S. Feuvret, L. Tallet-richard et al.,

, Cancer Radiother, vol.20, pp.80-87, 2016.

R. A. Patchell, P. A. Tibbs, J. W. Walsh, R. J. Dempsey, Y. Maruyama et al., A randomized trial of surgery in the treatment of single metastases to the brain, N Engl J Med, vol.322, pp.494-500, 1990.

A. J. Patel, D. Suki, M. A. Hatiboglu, H. Abouassi, W. Shi et al., Factors influencing the risk of local recurrence after resection of a single brain metastasis, J Neurosurg, vol.113, pp.181-190, 2010.

E. L. Chang, J. S. Wefel, K. R. Hess, P. K. Allen, F. F. Lang et al., Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus wholebrain irradiation: a randomised controlled trial, Lancet Oncol, vol.10, pp.1037-1081, 2009.

P. D. Brown, K. V. Ballman, J. H. Cerhan, S. K. Anderson, X. W. Carrero et al., Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial, Lancet Oncol, vol.18, pp.1049-60, 2017.

L. Leksell, The stereotaxic method and radiosurgery of the brain, Acta Chir Scand, vol.102, pp.316-325, 1951.

T. Murai, H. Ogino, Y. Manabe, M. Iwabuchi, T. Okumura et al., Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study, Clin Oncol R Coll Radiol G B, vol.26, pp.151-159, 2014.

M. J. Follwell, K. J. Khu, L. Cheng, W. Xu, D. J. Mikulis et al., Volume specific response criteria for brain metastases following salvage stereotactic radiosurgery and associated predictors of response, Acta Oncol Stockh Swed, vol.51, pp.629-664, 2012.

E. K. Donovan, S. Parpia, and J. N. Greenspoon, Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis, Curr Oncol Tor Ont, vol.26, pp.328-361, 2019.

J. H. Han, D. G. Kim, H. Chung, S. H. Paek, C. Park et al., Radiosurgery for Large Brain Metastases, Int J Radiat Oncol, vol.83, pp.113-133, 2012.

G. Minniti, C. Scaringi, S. Paolini, G. Lanzetta, A. Romano et al., Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis, Int J Radiat Oncol Biol Phys, vol.95, pp.1142-1150, 2016.

B. Zhao, J. Jin, N. Wen, Y. Huang, M. S. Siddiqui et al., Prescription to 50-75% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions, J Radiosurgery SBRT, vol.3, pp.139-186, 2014.

K. Ohtakara, S. Hayashi, and H. Hoshi, Dose gradient analyses in Linac-based intracranial stereotactic radiosurgery using Paddick's gradient index: consideration of the optimal method for plan evaluation, J Radiat Res (Tokyo), vol.52, pp.592-601, 2011.

W. J. Jeong, J. H. Park, E. J. Lee, J. H. Kim, C. J. Kim et al., Efficacy and Safety of Fractionated Stereotactic Radiosurgery for Large Brain Metastases, J Korean Neurosurg Soc, vol.58, pp.217-241, 2015.

K. H. Kim, D. Kong, K. R. Cho, M. H. Lee, J. Choi et al., Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study, J Neurosurg, vol.2019, pp.1-10

H. Kano, D. Kondziolka, J. Lobato-polo, Z. O. Flickinger, J. C. Lunsford et al., T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery, Neurosurgery, vol.66, pp.491-492, 2010.

E. Shaw, C. Scott, L. Souhami, R. Dinapoli, R. Kline et al., Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05, Int J Radiat Oncol Biol Phys, vol.47, pp.291-299, 2000.

G. Minniti, E. Clarke, G. Lanzetta, M. F. Osti, G. Trasimeni et al., Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis, Radiat Oncol Lond Engl, vol.6, p.48, 2011.

G. Minniti, D. 'angelillo, R. M. Scaringi, C. Trodella, L. E. Clarke et al., Fractionated stereotactic radiosurgery for patients with brain metastases, J Neurooncol, vol.117, pp.295-301, 2014.

B. J. Blonigen, R. D. Steinmetz, L. Levin, M. A. Lamba, R. E. Warnick et al., Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, vol.77, pp.996-1001, 2010.

E. J. Lehrer, J. L. Peterson, N. G. Zaorsky, P. D. Brown, A. Sahgal et al., Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials, Int J Radiat Oncol Biol Phys, vol.103, pp.618-648, 2019.

L. Feuvret, S. Vinchon, V. Martin, I. Lamproglou, A. Halley et al., Stereotactic radiotherapy for large solitary brain metastases, Cancer Radiother J Soc Francaise Radiother Oncol, vol.18, pp.97-106, 2014.

A. L. Zimmerman, E. S. Murphy, J. H. Suh, M. A. Vogelbaum, G. H. Barnett et al., Treatment of Large Brain Metastases With Stereotactic Radiosurgery, Technol Cancer Res Treat, vol.15, pp.186-95, 2016.

J. W. Kim, H. R. Park, J. M. Lee, J. W. Kim, H. Chung et al., Fractionated Stereotactic Gamma Knife Radiosurgery for Large Brain Metastases: A Retrospective, Single Center Study. PloS One, vol.11, p.163304, 2016.

H. K. Inoue, H. Sato, K. Seto, K. Torikai, Y. Suzuki et al., Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis, J Radiat Res (Tokyo), vol.55, pp.334-376, 2014.

H. K. Inoue, K. Seto, A. Nozaki, K. Torikai, Y. Suzuki et al., Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14), J Radiat Res (Tokyo), vol.54, pp.727-762, 2013.

Y. Higuchi, T. Serizawa, O. Nagano, S. Matsuda, J. Ono et al., Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors, Int J Radiat Oncol Biol Phys, vol.74, pp.1543-1551, 2009.

Z. A. Kohutek, Y. Yamada, T. A. Chan, C. W. Brennan, V. Tabar et al., Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases, J Neurooncol, vol.125, pp.149-56, 2015.

M. H. Lee, K. H. Kim, K. R. Cho, J. W. Choi, D. Kong et al., Volumetric changes of intracranial metastases during the course of fractionated stereotactic radiosurgery and significance of adaptive planning, J Neurosurg, vol.2019, pp.1-6

R. E. Wegner, J. E. Leeman, P. Kabolizadeh, J. Rwigema, A. H. Mintz et al., Fractionated stereotactic radiosurgery for large brain metastases, Am J Clin Oncol, vol.38, pp.135-144, 2015.

G. Minniti, C. Scaringi, G. Lanzetta, D. Anzellini, F. Bianciardi et al., Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC), Lung Cancer Amst Neth, vol.132, pp.119-144, 2019.

T. W. Griffin, T. F. Pajak, B. W. Gillespie, L. W. Davis, L. W. Brady et al., Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry, Int J Radiat Oncol Biol Phys, vol.10, pp.481-488, 1984.

L. Gaspar, C. Scott, M. Rotman, S. Asbell, T. Phillips et al., Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int J Radiat Oncol Biol Phys, vol.37, pp.745-51, 1997.

T. M. Churilla, I. H. Chowdhury, E. Handorf, L. Collette, S. Collette et al., Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial, JAMA Oncol, vol.5, pp.243-250, 2019.

T. Tan and P. M. Black, Image-guided craniotomy for cerebral metastases: techniques and outcomes, Neurosurgery, vol.61, pp.349-56, 2007.

J. L. Sanmillan, A. Fernández-coello, I. Fernández-conejero, G. Plans, and A. Gabarrós, Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region, J Neurosurg, vol.126, pp.698-707, 2017.

F. Cicone, G. Minniti, A. Romano, A. Papa, C. Scaringi et al., Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery, Eur J Nucl Med Mol Imaging, vol.42, pp.103-114, 2015.